Role of urokinase in the fibrogenic response of the lung to mineral particles

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 2, 1998, Pages 617-628

  Lardot, Cécile G ^a   Huaux, François A ^b   Broeckaert, Fabrice R ^b   Declerck, Paul J ^b   Delos, Monique ^b   Fubini, Bice ^b   Lison, Dominique F ^b  

^a Indust Toxicol and Occup Med U   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROGENESIS; FIBROSING ALVEOLITIS; KNOCKOUT MOUSE; LUNG LAVAGE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SILICOSIS;

EID: 0031911093     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.2.9707052     Document Type: Article

References (38)

1. Vassalli, J. D., A. P. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067-1072.
2. Murphy, G., S. Atkinson, R. Ward, J. Gavrilovic, and J. J. Reynolds. 1992. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann. N.Y. Acad. Sci. 667:1-12.
3. Chapman, H. A., P. Bertozzi, L. Z. Sailor, and A. R. Nusrat. 1990. Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface. Am. J. Physiol. 259:L432-L438.
4. Gross, T. J., R. H. Simon, C. J. Kelly, and R. G. Sitrin. 1991. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am. J. Physiol. Society 260:L286-L295.
5. Vassalli, J. D., A. Wohlwend, and D. Belin. 1992. Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: a localized and regulated proteolytic system. Curr. Top. Microbiol. Immunol. 181:65-86.
6. 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am. J. Respir. Cell Mol. Biol. 15:252-259.
7. Waltz, D. A., L. Z. Sailor, and H. A. Chapman. 1993. Cytokines induce urokinase-dependent adhesion of human myeloid cells: a regulatory role for plasminogen activator inhibitors. J. Clin. Invest. 91:1541-1552.
8. Gyetko, M. R., R. F. Todd, 3rd, C. C. Wilkinson, and R. G. Sitrin. 1994. The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest. 93:1380-1387.
9. De Petro, G., A. Copeta, and S. Barlati. 1994. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp. Cell Res. 213:286-294.
10. Shetty, S., A. Kumar, A. R. Johnson, S. Pueblitz, D. Holiday, G. Ragbu, and S. Idell. 1996. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Ant. J. Respir. Cell Mol. Biol. 15:78-87.
11. Chapman, H. A., X. L. Yang, L. Z. Sailor, and D. J. Sugarbaker. 1990. Developmental expression of plasminogen activator inhibitor type 1 by human alveolar macropaghes: possible role in lung injury. J. Immunol. 145:3398-3405.
12. Samad, F., G. Bergtrom, and D. L. Amrani. 1994. Regulation of plasminogen activation by interleukin-6 in human lung fibroblasts. Biochim. Biophys. Acta 1221:307-314.
13. Levi, M., D. Roem, A. M. Kamp, J. P. de Boer, C. E. Hack, and J. W. ten Cate. 1993. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo. Thromb. Haemost. 69:141-146.
14. Eitzman, D. T., R. D. McCoy, X. Zheng, W. P. Fay, T. Shen, D. Ginsburg, and R. H. Simon. 1996. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97:232-237.
15. Hart, D. A., P. Whidden, F. Green, J. Henkin, and D. E. Woods. 1994. Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model. Clin. Invest. Med. 17:69-76.
16. Idell, S., K. K. James, E. G. Levin, B. S. Schwartz, N. Manchanda, R. J. Maunder, T. R. Martin, J. McLarty, and D. S. Fair. 1989. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J. Clin. Invest. 84:695-705.
17. Bertozzi, P., B. Astedt, L. Zenzius, K. Lynch, F. LeMaire, W. Zapol, and H. A. Chapman, Jr. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome [see comments]. N. Engl. J. Med. 322:890-897.
18. Chapman, H. A., C. L. Allen, and O. L. Stone. 1986. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am. Rev. Respir. Dis. 133:437-443
19. Cantin, A., C. Allard, and R. Begin. 1989. Increased alveolar plasminogen activator in early asbestosis. Am. Rev. Respir. Dis. 139:604-609.
20. Brown, G. M., and K. Donaldson. 1989. Inflammatory responses in lungs of rats inhaling coalmine dust: enhanced proteolysis of fibronectin by bronchoalveolar leukocytes. Br. J. Ind. Med. 46:866-872.
21. Hubbard, A. K. 1989. Role for T lymphocytes in silica-induced pulmonary inflammation. Lab. Invest. 61:46-52.
22. Lasfargues, G., D. Lison, P. Maldague, and R. Lauwerys. 1992. Comparative study of the acute lung toxicity of pure cobalt powder and cobalt-tungsten carbide mixture in rat. Toxicol. Appl. Pharmacol. 112:41-50.
23. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J. J. van den Oord, D. Collen, and R. C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424.
24. Leprince, P., B. Register, and G. Moonen. 1989. A colorimetric assay for the simultaneous measurement of plasminogen activators and plasminogen activator inhibitors in serum-free conditioned media from cultured cells. Anal. Biochem. 17:341-346.
25. Schnyder, J., R. Marti, P. H. Cooper, and T. G. Payne. 1992. Spectrophotometric method to quantify and discriminate urokinase and tissue-type plasminogen activators. Anal. Biochem. 200:156-162.
26. Declerck, P. J., M. Verstreken, and D. Collen. 1995. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb. Haemost. 74:1305-1309.
27. Driscoll, K. E., J. K. Maurer, J. Poynter, J. Higgins, T. Asquith, and N. S. Miller. 1992. Stimulation of rat alveolar macrophage fibronectin release in a cadmium chloride model of lung injury and fibrosis. Toxicol. Appl. Pharmacol. 116:30-37.
28. Lasfargues, G., C. Lardot, M. Delos, R. Lauwerys, and D. Lison. 1995. The delayed lung responses to single and repeated intratracheal administration of pure cobalt and hard metal powder in the rat. Environ. Res. 69:108-121.
29. Lindenschmidt, R. C., K. E. Driscoll, M. A. Perkins, J. M. Higgins, J. K. Maurer, and K. A. Belfiore. 1990. The comparison of a fibrogenic and two nonfibrogenic dusts by bronchoalveolar lavage. Toxicol. Appl. Pharmacol. 102:268-281.
30. 2) by inhalation for two years. Toxicol. Appl. Pharmacol. 79:179-192.
31. Oberdorster, G., J. Ferin, R. Gelein, S. C. Soderholm, and J. Finkelstein. 1992. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ. Health Perspect. 97:193-199.
32. Morrow, P. E. 1992. Dust overloading of the lungs: update and appraisal. Toxicol. Appl. Pharmacol. 113:1-12.
33. Idell, S., K. K. James, C. Gillies, D. S. Fair, and R. S. Thrall. 1989. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am. J. Pathol. 135:387-399.
34. Sibille, Y., J. B. Martinot, L. L. Polomski, B. Wallaert, M. Demusis, J. A. Rankin, C. Voisin, and J. B. Gee. 1990. Phagocyte enzymes in bronchoalveolar lavage from patients with pulmonary sarcoidosis and collagen vascular disorders [published erratum appears in Eur. Respir. J. 1990 3(5):609]. Eur. Respir. J. 3:249-256.
35. Plesner, T., M. Ploug, V. Ellis, E. Ronne, G. Hoyer Hansen, M. Wittrup, T. L. Pedersen, T. Tscherning, K. Dano, and N. E. Hansen. 1994. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 83:808-815.
36. Pohl, W. R., M. G. Conlan, A. B. Thompson, R. F. Ertl, D. G. Romberger, D. F. Mosher, and S. I. Rennard. 1991. Vitronectin in bronchoalveolar lavage fluid is increased in patients with interstitial lung disease. Am. Rev. Respir. Dis. 143:1369-1375.
37. Wei, Y., D. A. Waltz, N. Rao, R. J. Drummond, S. Rosenberg, and H. A. Chapman. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380-32388.
38. Waltz, D. A., and H. A. Chapman. 1994. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269: 14746-14750.